ATOMED atorvastatin (as calcium) 10 mg tablet film-coated blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

atorvastatin calcium trihydrate, Quantity: 10.844 mg (Equivalent: atorvastatin, Qty 10 mg)

Pieejams no:

Micro Labs Pty Ltd

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: magnesium stearate; calcium carbonate; microcrystalline cellulose; croscarmellose sodium; hyprolose; lactose monohydrate; polysorbate 80; titanium dioxide; macrogol 8000; hypromellose; purified talc

Ievadīšanas:

Oral

Vienības iepakojumā:

30, 10

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Atorvastatin is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.,Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.,Atorvastatin is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see section 5.1, Pharmacodynamic properties, Clinical trials, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction (MI) and non-fatal stroke.,These effects do not replace the need to independently control known causes of cardiovascular (CV) mortality and morbidity such as hypertension, diabetes and smoking.

Produktu pārskats:

Visual Identification: White to off-white, oval shaped, film coated tablet debossed with "I" on one side and "90" on the other side approximately 9.70mm lengthx5.10 mm width; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

2022-01-13